Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03594448 · ClinicalTrials.gov registry record
Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients
A clinical trial, sponsored by University of Southern California.
- Terminated
- Registry status
- 6
- Enrollment target
NCT03594448 is a clinical trial that was terminated before completion, run by University of Southern California. The registered enrollment target is 6 participants.
The verdict
NCT03594448 was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
This pilot trial studies how well serial liquid biopsies work in detecting microsatellite instability in participants with stage IV colorectal cancer. Serial liquid biopsies may help doctors learn better methods to track cancer in the bloodstream and how to use these to improve cancer treatments.
Interventions
- PROCEDURE Specimen Collection
- PROCEDURE Serial Liquid Biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-09-05 |
| Est. Completion | 2023-09-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03594448
The ClinicalTrials.gov registry entry for NCT03594448 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Specimen Collection is the first listed.
NCT03594448 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03594448 about?
NCT03594448 is a clinical study titled "Detection of MSI in Circulating Tumor DNA of Colorectal Carcinoma Patients". This pilot trial studies how well serial liquid biopsies work in detecting microsatellite instability in participants with stage IV colorectal cancer. Serial liquid biopsies may help doctors learn better methods to track cancer in the bloodstream and how to use these to improve cancer treatments.
What is the current status of trial NCT03594448?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2018-09-05. Estimated completion is 2023-09-18.
What interventions are being tested in trial NCT03594448?
The interventions under investigation include: Specimen Collection (PROCEDURE), Serial Liquid Biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT03594448?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.